The Biotech Growth Trust (BIOG) Competitors GBX 970 +16.00 (+1.68%) As of 11:52 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock BIOG vs. JEO, MUT, APEO, ICGT, TFIF, RICA, SDP, SAIN, SLPE, and CGTShould you be buying The Biotech Growth Trust stock or one of its competitors? The main competitors of The Biotech Growth Trust include European Opportunities Trust (JEO), Murray Income Trust (MUT), abrdn Private Equity Opportunities (APEO), ICG Enterprise Trust (ICGT), TwentyFour Income (TFIF), Ruffer Investment (RICA), Schroder Investment Trust - Schroder AsiaPacific Fund (SDP), Scottish American Investment (SAIN), Standard Life Private Equity Trust (SLPE), and Capital Gearing (CGT). These companies are all part of the "asset management" industry. The Biotech Growth Trust vs. Its Competitors European Opportunities Trust Murray Income Trust abrdn Private Equity Opportunities ICG Enterprise Trust TwentyFour Income Ruffer Investment Schroder Investment Trust - Schroder AsiaPacific Fund Scottish American Investment Standard Life Private Equity Trust Capital Gearing European Opportunities Trust (LON:JEO) and The Biotech Growth Trust (LON:BIOG) are both small-cap asset management industry companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, profitability and media sentiment. Do insiders and institutionals hold more shares of JEO or BIOG? 10.5% of The Biotech Growth Trust shares are held by institutional investors. 2.4% of The Biotech Growth Trust shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has stronger valuation and earnings, JEO or BIOG? The Biotech Growth Trust has lower revenue, but higher earnings than European Opportunities Trust. The Biotech Growth Trust is trading at a lower price-to-earnings ratio than European Opportunities Trust, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEuropean Opportunities Trust-£62.33M0.00N/A-£65.20N/AThe Biotech Growth Trust-£78.81M-2.94£83.83M-£2.62-369.81 Does the media refer more to JEO or BIOG? In the previous week, The Biotech Growth Trust had 1 more articles in the media than European Opportunities Trust. MarketBeat recorded 1 mentions for The Biotech Growth Trust and 0 mentions for European Opportunities Trust. The Biotech Growth Trust's average media sentiment score of 1.42 beat European Opportunities Trust's score of 0.00 indicating that The Biotech Growth Trust is being referred to more favorably in the news media. Company Overall Sentiment European Opportunities Trust Neutral The Biotech Growth Trust Positive Is JEO or BIOG more profitable? The Biotech Growth Trust has a net margin of 95.33% compared to European Opportunities Trust's net margin of 0.00%. The Biotech Growth Trust's return on equity of 26.96% beat European Opportunities Trust's return on equity.Company Net Margins Return on Equity Return on Assets European Opportunities TrustN/A N/A N/A The Biotech Growth Trust 95.33%26.96%12.39% SummaryThe Biotech Growth Trust beats European Opportunities Trust on 8 of the 10 factors compared between the two stocks. Get The Biotech Growth Trust News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIOG vs. The Competition Export to ExcelMetricThe Biotech Growth TrustAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£231.31M£1.49B£6.46B£2.60BDividend YieldN/A4.60%4.31%5.32%P/E Ratio-369.814,731.421,778.555,398.40Price / Sales-2.941,968.421,363.6897,640.86Price / Cash87.7460.4749.0227.93Price / Book0.901.362.108.91Net Income£83.83M£264.59M£1.23B£5.89B7 Day Performance5.90%0.13%1.44%0.56%1 Month Performance8.99%1.07%2.69%2.72%1 Year Performance-8.32%9.14%34.89%198.81% The Biotech Growth Trust Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOGThe Biotech Growth TrustN/AGBX 970+1.7%N/A-9.8%£231.31M-£78.81M-369.81N/APositive NewsJEOEuropean Opportunities TrustN/AN/AN/AN/A£886.70M-£62.33M-12.93N/AMUTMurray Income TrustN/AGBX 900+0.4%N/A+3.5%£881.03M£27.79M3,703.70147,000Positive NewsDividend CutAPEOabrdn Private Equity OpportunitiesN/AN/AN/AN/A£880.29M£80.21M1,435.00N/AICGTICG Enterprise TrustN/AGBX 1,396-0.4%N/A+18.7%£877.72M£117.70M852.21N/ATFIFTwentyFour IncomeN/AGBX 113-0.4%N/A+6.2%£869.01M£106.24M807.14N/ARICARuffer InvestmentN/AGBX 288.50+0.7%N/A+4.4%£859.96M-£2.33M-20,034.72N/ASDPSchroder Investment Trust - Schroder AsiaPacific FundN/AGBX 635+0.5%N/A+23.6%£859.92M£55.98M2,003.79N/APositive NewsSAINScottish American InvestmentN/AGBX 505-0.8%N/A-0.4%£854.76M£13.77M8,875.22N/ASLPEStandard Life Private Equity TrustN/AGBX 555+0.2%N/A+1.7%£853.29M£289.51M298.07N/ACGTCapital GearingN/AGBX 4,865flatN/A+1.9%£818.73M£37.55M2,705.78N/A Related Companies and Tools Related Companies JEO Alternatives MUT Alternatives APEO Alternatives ICGT Alternatives TFIF Alternatives RICA Alternatives SDP Alternatives SAIN Alternatives SLPE Alternatives CGT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:BIOG) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Biotech Growth Trust PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share The Biotech Growth Trust With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.